Coronavirus Stock Reckoning
For all the harm that COVID-19 has wrought around the world, both in terms of the loss of lives and the economic devastation that followed, there has been one beneficiary of the current economic conditions: pharma stocks. Namely, pharma companies that have been looking into a COVID-19 cure, a group I have come to deem to be at the forefront of a new class of securities: coronavirus stocks.
The thing about coronavirus stocks, or at least the ones looking to directly profit from a.
Den vollständigen Artikel lesen ...
For all the harm that COVID-19 has wrought around the world, both in terms of the loss of lives and the economic devastation that followed, there has been one beneficiary of the current economic conditions: pharma stocks. Namely, pharma companies that have been looking into a COVID-19 cure, a group I have come to deem to be at the forefront of a new class of securities: coronavirus stocks.
The thing about coronavirus stocks, or at least the ones looking to directly profit from a.
Den vollständigen Artikel lesen ...